PRESS RELEASE published on 01/29/2025 at 12:30, 10 months 7 days ago NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 NanoViricides, Inc. presents its groundbreaking broad-spectrum antiviral drug NV-387 at MicroCap Conference 2025, showing promising results against various viral infections NanoViricides NV-387 Microcap Conference Antiviral Drug Viral Infections
BRIEF published on 01/27/2025 at 12:35, 10 months 9 days ago NanoViricides Advances NV-387 to Phase II Clinical Trial NanoViricides NV-387 Clinical Trial Antiviral Drug MPOX Treatment
BRIEF published on 01/27/2025 at 12:35, 10 months 9 days ago NanoViricides fait passer le NV-387 à l'essai clinique de phase II NanoViricides NV-387 Essai Clinique Médicament Antiviral Traitement MPox
PRESS RELEASE published on 01/27/2025 at 12:30, 10 months 9 days ago NanoViricides Engages CRO for Phase II Clinical Trial NanoViricides, Inc. engages a Clinical Research Organization for Phase II trial of broad-spectrum antiviral drug NV-387 targeting MPox virus infection. Drug aims to combat viral diseases effectively NanoViricides NV-387 Clinical Trial Antiviral Drug Mpox Virus
BRIEF published on 01/13/2025 at 12:35, 10 months 23 days ago NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
BRIEF published on 01/13/2025 at 12:35, 10 months 23 days ago NanoViricides présentera ses avancées antivirales révolutionnaires au Biotech Showcase NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Vitrine Biotechnologique
PRESS RELEASE published on 01/13/2025 at 12:30, 10 months 23 days ago NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
BRIEF published on 01/08/2025 at 12:35, 10 months 28 days ago Broad-Spectrum Antivirals: A Necessity Amid Multiple Viral Threats NanoViricides NV-387 Broad-spectrum Antivirals RNA Viruses Viral Resistance
BRIEF published on 01/08/2025 at 12:35, 10 months 28 days ago Antiviraux à large spectre : une nécessité face aux multiples menaces virales NanoViricides NV-387 Antiviraux À Large Spectre Virus À ARN Résistance Virale
PRESS RELEASE published on 01/08/2025 at 12:30, 10 months 28 days ago Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals NanoViricides, Inc. President Dr. Anil Diwan comments on multiple pandemic-causing viruses worldwide, highlighting NV-387's broad-spectrum antiviral capabilities NanoViricides NV-387 Antiviral Broad-spectrum Pandemic
Published on 12/05/2025 at 20:25, 40 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 50 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 15 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 45 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 20 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 2 hours 7 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 50 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 19 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 47 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 47 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 54 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 54 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 7 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
